Infervision
PrivateLast Round
Series D
Aug 13, 2021
Total Funding Raised
$215.1M
Company Overview
Infervision is a healthcare technology company that develops artificial intelligence-assisted medical imaging diagnosis equipment to enhance diagnostic accuracy, improve outcomes, reduce costs, and increase efficiency for doctors and medical institutions.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical AI, Healthcare Analytics, Computer Vision
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Infervision Comparables
Compare Infervision with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DeepWise | 92% | |
| Shukun Technology | 90% | |
| Qure.ai | 89% |
Infervision Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Aug 13, 2021 | ||||
| Series C | Dec 7, 2018 | ||||
| Series B Extension | Mar 19, 2018 | ||||
| Series B | Sep 21, 2017 | ||||
| Series A | Jan 14, 2017 | ||||
Angel | Feb 24, 2016 |
Infervision Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CDH Investments | Series D, Series C |
| Taihe Capital | Series C |
| V-Capital | Series D |
| Gaingels | Series B Extension, Series B |
| Goldman Sachs Asset Management Private Equity | Series D |
| Z-Park Fund | Series D |
| Genesis Capital | Series B Extension, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 7, 2018
Led by CDH Investments with participation from Sequoia Capital.
Infervision Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Infervision's valuation, stock price, and market status.
Is Infervision a public or private company?
Infervision is a private company.
What is the current stock price of Infervision?
Infervision is a private company with no public stock price. No recent secondary market data is available.
How much is Infervision worth (valuation)?
Valuation information for Infervision is not publicly available.
Can I buy Infervision stock?
Infervision shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Infervision's last funding round?
Infervision's most recent funding round was Series D on August 13, 2021.
Who are the main investors in Infervision?
Key investors in Infervision include CDH Investments, Goldman Sachs Asset Management Private Equity, Goldman Sachs Growth Equity, Qiming Venture Partners, HongShan.
Will Infervision IPO soon?
No public IPO plans have been announced for Infervision.
How can I track Infervision secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Infervision's secondary market activity and sign up for updates.